HER2 in high-risk rectal cancer patients treated in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab
Titel:
HER2 in high-risk rectal cancer patients treated in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab
Auteur:
Sclafani, F. Roy, A. Cunningham, D. Wotherspoon, A. Peckitt, C. Gonzalez de Castro, D. Tabernero, J. Glimelius, B. Cervantes, A. Eltahir, Z. Oates, J. Chau, I.